Science-Driven Delivery Systems for Superior Therapeutic Outcomes

At Medkem, we believe that a molecule’s success depends on how it is delivered. Our Formulation Research & Development (FR&D) team specializes in the complex science of combining active ingredients with the right excipients to create stable, effective, and patient-friendly dosage forms.

We bridge the gap between a raw API and a finished drug product, ensuring that your medication is not only chemically potent but also biologically optimized.

Our Comprehensive FR&D Services

Our laboratories are equipped to handle the entire formulation lifecycle, from initial pre-formulation studies to final process validation.

  1. Pre-Formulation Studies

Before we design the dosage form, we deeply understand the molecule.

  • Physicochemical Characterization:Analysing solubility, pKa, partition coefficient, and hygroscopicity.
  • Excipient Compatibility:Conducting rigorous “drug-excipient” interaction studies to ensure long-term stability.
  • Solid-State Characterization:Evaluating polymorphism and particle size distribution to ensure manufacturing consistency.
  1. Dosage Form Design & Development

We develop a wide array of delivery systems tailored to the therapeutic need:

  • Oral Solids:Immediate-release and modified-release tablets, capsules, and multi-particulate systems (pellets).
  • Liquid & Semi-Solids:Oral liquids, suspensions, and topical creams or ointments.
  • Specialized Delivery:Taste-masking for paediatric formulations and solubility enhancement for poorly soluble drugs (using techniques like solid dispersions).
  1. Analytical Method Development & Stability Testing

Every formulation is backed by data.

  • Dissolution Profiling:Ensuring the drug is released at the right time and place in the body.
  • ICH Stability Studies:Testing formulations under accelerated and long-term conditions (humidity/temperature) to determine shelf-life.
  • Bioavailability Enhancement:Optimizing the formula to ensure maximum absorption and therapeutic efficacy.

The Medkem Advantage in FR&D

  • Quality by Design (QbD):We don’t use trial and error. We apply QbD principles to identify critical material attributes and process parameters early, ensuring a “right-first-time” approach to development.
  • Scalability-Focused R&D:We develop formulations with large-scale manufacturing in mind. Our lab processes are designed to be easily transferable to commercial production lines without losing integrity.
  • Patient-Centric Approach:We focus on the end-user—optimizing tablet size, ease of swallowing, and dosing frequency to improve patient compliance.
  • Technology-Driven Solutions:From high-shear granulation to advanced coating technologies, we utilize state-of-the-art equipment to solve complex formulation challenges.

From Lab Bench to Patient Bedside

Don’t just launch a drug—launch a superior delivery system. Partner with Medkem’s FR&D team to maximize the potential of your therapeutic assets.

Discuss Your Formulation Challenge